639 reports of this reaction
1.5% of all ORLISTAT reports
#16 most reported adverse reaction
FREQUENT BOWEL MOVEMENTS is the #16 most commonly reported adverse reaction for ORLISTAT, manufactured by Haleon US Holdings LLC. There are 639 FDA adverse event reports linking ORLISTAT to FREQUENT BOWEL MOVEMENTS. This represents approximately 1.5% of all 43,367 adverse event reports for this drug.
Patients taking ORLISTAT who experience frequent bowel movements should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FREQUENT BOWEL MOVEMENTS is a less commonly reported adverse event for ORLISTAT, but still significant enough to appear in the safety profile.
In addition to frequent bowel movements, the following adverse reactions have been reported for ORLISTAT:
The following drugs have also been linked to frequent bowel movements in FDA adverse event reports:
FREQUENT BOWEL MOVEMENTS has been reported as an adverse event in 639 FDA reports for ORLISTAT. This does not prove causation, but indicates an association observed in post-market surveillance data.
FREQUENT BOWEL MOVEMENTS accounts for approximately 1.5% of all adverse event reports for ORLISTAT, making it a notable side effect.
If you experience frequent bowel movements while taking ORLISTAT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.